CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients with cancer. Although incorporation of costimulatory endodomains within these CARs increases the proliferation of CAR-redirected T lymphocytes,...
Saved in:
Published in | The Journal of clinical investigation Vol. 121; no. 5; pp. 1822 - 1826 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Clinical Investigation
01.05.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients with cancer. Although incorporation of costimulatory endodomains within these CARs increases the proliferation of CAR-redirected T lymphocytes, it has proven difficult to draw definitive conclusions about the specific effects of costimulatory endodomains on the expansion, persistence, and antitumor effectiveness of CAR-redirected T cells in human subjects, owing to the lack of side-by-side comparisons with T cells bearing only a single signaling domain. We therefore designed a study that allowed us to directly measure the consequences of adding a costimulatory endodomain to CAR-redirected T cells. Patients with B cell lymphomas were simultaneously infused with 2 autologous T cell products expressing CARs with the same specificity for the CD19 antigen, present on most B cell malignancies. One CAR encoded both the costimulatory CD28 and the ζ-endodomains, while the other encoded only the ζ-endodomain. CAR+ T cells containing the CD28 endodomain showed strikingly enhanced expansion and persistence compared with CAR+ T cells lacking this endodomain. These results demonstrate the superiority of CARs with dual signal domains and confirm a method of comparing CAR-modified T cells within individual patients, thereby avoiding patient-to-patient variability and accelerating the development of optimal T cell immunotherapies. |
---|---|
AbstractList | Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients with cancer. Although incorporation of costimulatory endodomains within these CARs increases the proliferation of CAR-redirected T lymphocytes, it has proven difficult to draw definitive conclusions about the specific effects of costimulatory endodomains on the expansion, persistence, and antitumor effectiveness of CAR-redirected T cells in human subjects, owing to the lack of side-by-side comparisons with T cells bearing only a single signaling domain. We therefore designed a study that allowed us to directly measure the consequences of adding a costimulatory endodomain to CAR-redirected T cells. Patients with B cell lymphomas were simultaneously infused with 2 autologous T cell products expressing CARs with the same specificity for the CD19 antigen, present on most B cell malignancies. One CAR encoded both the costimulatory CD28 and the ζ-endodomains, while the other encoded only the ζ-endodomain. CAR+ T cells containing the CD28 endodomain showed strikingly enhanced expansion and persistence compared with CAR+ T cells lacking this endodomain. These results demonstrate the superiority of CARs with dual signal domains and confirm a method of comparing CAR-modified T cells within individual patients, thereby avoiding patient-to-patient variability and accelerating the development of optimal T cell immunotherapies. Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients with cancer. Although incorporation of costimulatory endodomains within these CARs increases the proliferation of CAR-redirected T lymphocytes, it has proven difficult to draw definitive conclusions about the specific effects of costimulatory endodomains on the expansion, persistence, and antitumor effectiveness of CAR-redirected T cells in human subjects, owing to the lack of side-by-side comparisons with T cells bearing only a single signaling domain. We therefore designed a study that allowed us to directly measure the consequences of adding a costimulatory endodomain to CAR-redirected T cells. Patients with B cell lymphomas were simultaneously infused with 2 autologous T cell products expressing CARs with the same specificity for the CD19 antigen, present on most B cell malignancies. One CAR encoded both the costimulatory CD28 and the ζ-endodomains, while the other encoded only the ζ-endodomain. CAR+ T cells containing the CD28 endodomain showed strikingly enhanced expansion and persistence compared with CAR+ T cells lacking this endodomain. These results demonstrate the superiority of CARs with dual signal domains and confirm a method of comparing CAR-modified T cells within individual patients, thereby avoiding patient-to-patient variability and accelerating the development of optimal T cell immunotherapies.Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients with cancer. Although incorporation of costimulatory endodomains within these CARs increases the proliferation of CAR-redirected T lymphocytes, it has proven difficult to draw definitive conclusions about the specific effects of costimulatory endodomains on the expansion, persistence, and antitumor effectiveness of CAR-redirected T cells in human subjects, owing to the lack of side-by-side comparisons with T cells bearing only a single signaling domain. We therefore designed a study that allowed us to directly measure the consequences of adding a costimulatory endodomain to CAR-redirected T cells. Patients with B cell lymphomas were simultaneously infused with 2 autologous T cell products expressing CARs with the same specificity for the CD19 antigen, present on most B cell malignancies. One CAR encoded both the costimulatory CD28 and the ζ-endodomains, while the other encoded only the ζ-endodomain. CAR+ T cells containing the CD28 endodomain showed strikingly enhanced expansion and persistence compared with CAR+ T cells lacking this endodomain. These results demonstrate the superiority of CARs with dual signal domains and confirm a method of comparing CAR-modified T cells within individual patients, thereby avoiding patient-to-patient variability and accelerating the development of optimal T cell immunotherapies. Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients with cancer. Although incorporation of costimulatory endodomains within these CARs increases the proliferation of CAR-redirected T lymphocytes, it has proven difficult to draw definitive conclusions about the specific effects of costimulatory endodomains on the expansion, persistence, and antitumor effectiveness of CAR-redirected T cells in human subjects, owing to the lack of side-by-side comparisons with T cells bearing only a single signaling domain. We therefore designed a study that allowed us to directly measure the consequences of adding a costimulatory endodomain to CAR-redirected T cells. Patients with B cell lymphomas were simultaneously infused with 2 autologous T cell products expressing CARs with the same specificity for the CD19 antigen, present on most B cell malignancies. One CAR encoded both the costimulatory CD28 and the ζ-endodomains, while the other encoded only the ζ-endodomain. CAR + T cells containing the CD28 endodomain showed strikingly enhanced expansion and persistence compared with CAR + T cells lacking this endodomain. These results demonstrate the superiority of CARs with dual signal domains and confirm a method of comparing CAR-modified T cells within individual patients, thereby avoiding patient-to-patient variability and accelerating the development of optimal T cell immunotherapies. |
Audience | Academic |
Author | Liu, Hao Rooney, Cliona M. Brenner, Malcolm K. Gee, Adrian P. Heslop, Helen E. Mims, Martha P. Savoldo, Barbara Ramos, Carlos Almeida Liu, Enli Dotti, Gianpietro Kamble, Rammurti T. Mei, Zhuyong Bollard, Catherine M. Grilley, Bambi Carrum, George Keating, Michael J. |
AuthorAffiliation | 1 Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA. 2 Department of Pediatrics, Texas Children’s Hospital, Houston, Texas, USA. 3 Department of Medicine, Baylor College of Medicine, Houston, Texas, USA. 4 The Methodist Hospital, Houston, Texas, USA. 5 The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 6 Biostatistics Core of the Dan L. Duncan Cancer Center, Houston, Texas, USA. 7 Department of Virology and 8 Department of Immunology, Baylor College of Medicine, Houston, Texas, USA |
AuthorAffiliation_xml | – name: 1 Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA. 2 Department of Pediatrics, Texas Children’s Hospital, Houston, Texas, USA. 3 Department of Medicine, Baylor College of Medicine, Houston, Texas, USA. 4 The Methodist Hospital, Houston, Texas, USA. 5 The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 6 Biostatistics Core of the Dan L. Duncan Cancer Center, Houston, Texas, USA. 7 Department of Virology and 8 Department of Immunology, Baylor College of Medicine, Houston, Texas, USA |
Author_xml | – sequence: 1 givenname: Barbara surname: Savoldo fullname: Savoldo, Barbara – sequence: 2 givenname: Carlos Almeida surname: Ramos fullname: Ramos, Carlos Almeida – sequence: 3 givenname: Enli surname: Liu fullname: Liu, Enli – sequence: 4 givenname: Martha P. surname: Mims fullname: Mims, Martha P. – sequence: 5 givenname: Michael J. surname: Keating fullname: Keating, Michael J. – sequence: 6 givenname: George surname: Carrum fullname: Carrum, George – sequence: 7 givenname: Rammurti T. surname: Kamble fullname: Kamble, Rammurti T. – sequence: 8 givenname: Catherine M. surname: Bollard fullname: Bollard, Catherine M. – sequence: 9 givenname: Adrian P. surname: Gee fullname: Gee, Adrian P. – sequence: 10 givenname: Zhuyong surname: Mei fullname: Mei, Zhuyong – sequence: 11 givenname: Hao surname: Liu fullname: Liu, Hao – sequence: 12 givenname: Bambi surname: Grilley fullname: Grilley, Bambi – sequence: 13 givenname: Cliona M. surname: Rooney fullname: Rooney, Cliona M. – sequence: 14 givenname: Helen E. surname: Heslop fullname: Heslop, Helen E. – sequence: 15 givenname: Malcolm K. surname: Brenner fullname: Brenner, Malcolm K. – sequence: 16 givenname: Gianpietro surname: Dotti fullname: Dotti, Gianpietro |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21540550$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks1u1DAQxyNURLcFiSdAFkh8HFJsJ_Y6F6Rq-VpUqRIUrpHXGe-6SuxgO1XLiXfgDXkSHLZdurAH5IOl8W_-45n5H2R71lnIsocEHxEypS8_zOYlJwTfySaEMZELWoi9bIIxJXk1LcR-dhDCOcakLFl5L9unhJWYMTzJvs1eU4GUC9F0QyujcRaZrvfuAgKCy17aMIakbVAPPpgQwSpATiO1Mh14o9JbNEuwyIOCPjr_8_uPzjVGG2jQGVLQtgEZi9qrrl-5TqI-VQEbw_3srpZtgAfX92H2-e2bs9n7_OT03Xx2fJIrjmnMJaNFVclKSq5KqdhCalLqUjOqlaiEpETrkvJyscCiwAs5lZhj3PBKcCg1kOIwe7XW7YdFB41Ktb1s696bTvqr2klTb79Ys6qX7qIukuC0Ykng2bWAd18HCLHuTBj7khbcEGrBGRFTXhWJfPwXee4Gb1N3CeIF54KUCXqyhpayhdpY7VJVNUrWx5RxipnA46_zHVSaM6Qvpu1rk8Jb_NEOPp0GOqN2JrzYSkhMhMu4lEMI9fzTx_9nT79ss09vsSuQbVwF1w6jtcI2-Oj2XjYLuTFnAp6vAeVdCB70BiG4Hn1f3_j-T_cbVJn4281pCqb9N-EXofMCIA |
CitedBy_id | crossref_primary_10_1007_s12185_013_1493_7 crossref_primary_10_1007_s00262_012_1254_0 crossref_primary_10_1182_bloodadvances_2016000034 crossref_primary_10_1200_JCO_2014_56_2025 crossref_primary_10_1007_s12026_011_8253_7 crossref_primary_10_1146_annurev_cancerbio_050216_034351 crossref_primary_10_2217_imt_2017_0133 crossref_primary_10_12659_MSM_890496 crossref_primary_10_1007_s13238_017_0400_z crossref_primary_10_1016_S1470_2045_13_70173_6 crossref_primary_10_1016_j_cmet_2022_02_009 crossref_primary_10_1016_j_apsb_2018_03_001 crossref_primary_10_1038_mt_2016_106 crossref_primary_10_1038_gt_2015_4 crossref_primary_10_1007_s10238_024_01347_7 crossref_primary_10_1111_cei_13592 crossref_primary_10_1182_blood_2011_03_344275 crossref_primary_10_3390_cancers13133236 crossref_primary_10_1016_j_molonc_2015_10_012 crossref_primary_10_1158_1078_0432_CCR_13_1016 crossref_primary_10_3390_cancers13051050 crossref_primary_10_1016_j_biopha_2024_117388 crossref_primary_10_1016_j_ymthe_2016_10_016 crossref_primary_10_1073_pnas_1610544113 crossref_primary_10_3390_cancers13102503 crossref_primary_10_1016_j_bbrc_2013_07_030 crossref_primary_10_1080_14712598_2017_1339687 crossref_primary_10_1111_sji_12331 crossref_primary_10_3390_cancers15051357 crossref_primary_10_2217_imt_2017_0026 crossref_primary_10_1016_j_hbpd_2018_05_005 crossref_primary_10_1038_gt_2012_21 crossref_primary_10_1371_journal_pone_0152196 crossref_primary_10_1053_j_seminoncol_2016_02_006 crossref_primary_10_1089_hgtb_2011_199 crossref_primary_10_1177_20406207211017788 crossref_primary_10_1155_2017_5604891 crossref_primary_10_1182_blood_2013_04_493361 crossref_primary_10_1208_s12248_019_0322_1 crossref_primary_10_1089_hum_2018_119 crossref_primary_10_3389_fimmu_2018_02380 crossref_primary_10_1158_1078_0432_CCR_13_2218 crossref_primary_10_1016_j_eng_2021_10_018 crossref_primary_10_3389_fimmu_2017_00457 crossref_primary_10_1016_j_intimp_2024_113717 crossref_primary_10_3390_jcm8020200 crossref_primary_10_1002_jgm_2604 crossref_primary_10_1038_s41416_023_02332_9 crossref_primary_10_1158_2326_6066_CIR_15_0276 crossref_primary_10_1007_s11899_012_0145_y crossref_primary_10_1038_pcan_2012_49 crossref_primary_10_1016_j_bbmt_2018_03_021 crossref_primary_10_1093_jnci_djv439 crossref_primary_10_1007_s00262_014_1568_1 crossref_primary_10_1016_j_jcyt_2016_07_004 crossref_primary_10_1111_bjh_13340 crossref_primary_10_3324_haematol_2019_231183 crossref_primary_10_1172_JCI86721 crossref_primary_10_1007_s12026_021_09236_x crossref_primary_10_1016_j_exphem_2018_07_002 crossref_primary_10_1186_s13287_020_02128_1 crossref_primary_10_1517_14712598_2016_1150996 crossref_primary_10_1002_iid3_1091 crossref_primary_10_1182_asheducation_2016_1_390 crossref_primary_10_1016_j_medcle_2020_05_030 crossref_primary_10_1038_cgt_2016_82 crossref_primary_10_3390_ijms20246223 crossref_primary_10_3390_jcm11082158 crossref_primary_10_1126_scitranslmed_abk1900 crossref_primary_10_3390_cancers14061501 crossref_primary_10_3389_fimmu_2020_01704 crossref_primary_10_1007_s11427_016_5036_3 crossref_primary_10_1016_j_ymthe_2017_12_003 crossref_primary_10_1111_bjh_15753 crossref_primary_10_1158_1078_0432_CCR_16_1421 crossref_primary_10_1016_j_celrep_2017_09_015 crossref_primary_10_1038_s41571_021_00476_2 crossref_primary_10_1371_journal_pone_0144787 crossref_primary_10_3390_cancers12040842 crossref_primary_10_1007_s12185_016_2039_6 crossref_primary_10_2139_ssrn_4087366 crossref_primary_10_3390_cancers13215445 crossref_primary_10_1016_j_omto_2021_08_014 crossref_primary_10_1016_j_bbrep_2022_101399 crossref_primary_10_3390_ph8020230 crossref_primary_10_1002_cam4_6497 crossref_primary_10_1007_s11864_020_00772_6 crossref_primary_10_1016_j_addr_2022_114358 crossref_primary_10_3390_cancers14215276 crossref_primary_10_1039_C9AN01811E crossref_primary_10_1182_blood_2014_01_552174 crossref_primary_10_1016_j_addr_2016_05_019 crossref_primary_10_1200_JCO_2016_71_3024 crossref_primary_10_1007_s00432_023_04996_5 crossref_primary_10_1016_j_omtm_2018_01_009 crossref_primary_10_1080_17843286_2018_1545373 crossref_primary_10_3389_fphar_2014_00235 crossref_primary_10_1016_j_bpj_2023_09_004 crossref_primary_10_1200_JCO_2014_60_3449 crossref_primary_10_1016_j_imlet_2019_06_002 crossref_primary_10_1038_s41586_018_0178_z crossref_primary_10_1126_science_aaf6756 crossref_primary_10_1200_JCO_20_01749 crossref_primary_10_1016_j_jcyt_2013_10_002 crossref_primary_10_4161_onci_22524 crossref_primary_10_1007_s11427_016_5023_8 crossref_primary_10_1016_j_stem_2015_03_011 crossref_primary_10_1007_s11912_019_0789_z crossref_primary_10_1089_hum_2012_143 crossref_primary_10_1172_JCI83476 crossref_primary_10_1016_j_trsl_2012_11_002 crossref_primary_10_1126_scitranslmed_3005930 crossref_primary_10_1097_PPO_0000000000000155 crossref_primary_10_1080_17474086_2019_1629901 crossref_primary_10_3389_fonc_2020_608916 crossref_primary_10_1016_j_jcyt_2014_12_002 crossref_primary_10_1097_PPO_0000000000000153 crossref_primary_10_3389_fonc_2019_01529 crossref_primary_10_3390_ijms21103525 crossref_primary_10_1016_j_isci_2024_111669 crossref_primary_10_2217_imt_15_6 crossref_primary_10_1586_ehm_12_38 crossref_primary_10_1038_s41571_021_00530_z crossref_primary_10_1089_hum_2013_075 crossref_primary_10_1007_s43152_024_00055_4 crossref_primary_10_3389_fimmu_2020_603237 crossref_primary_10_3389_fped_2021_784024 crossref_primary_10_1016_j_jcyt_2019_04_005 crossref_primary_10_1155_2019_5727516 crossref_primary_10_1111_bjh_15851 crossref_primary_10_3390_ijms252212201 crossref_primary_10_1016_j_smim_2020_101437 crossref_primary_10_1038_nm_4478 crossref_primary_10_1038_s41698_022_00272_w crossref_primary_10_3390_cancers14040967 crossref_primary_10_3390_ijms242115688 crossref_primary_10_1016_j_critrevonc_2020_103031 crossref_primary_10_1182_blood_2013_11_492231 crossref_primary_10_15264_cpho_2020_27_1_14 crossref_primary_10_3389_fimmu_2024_1489827 crossref_primary_10_1189_jlb_5BT1115_524R crossref_primary_10_22270_jddt_v14i6_6601 crossref_primary_10_1038_cr_2016_154 crossref_primary_10_1111_imr_12774 crossref_primary_10_1080_2162402X_2018_1433518 crossref_primary_10_1038_leu_2015_247 crossref_primary_10_1177_1756284818808086 crossref_primary_10_1371_journal_pone_0031210 crossref_primary_10_1016_j_canlet_2012_09_015 crossref_primary_10_1016_j_canlet_2020_11_044 crossref_primary_10_1080_2162402X_2015_1046673 crossref_primary_10_3389_fimmu_2018_00283 crossref_primary_10_3390_cells11020269 crossref_primary_10_1016_j_ijpharm_2017_07_075 crossref_primary_10_1016_j_canlet_2017_11_005 crossref_primary_10_1021_acsnano_3c10180 crossref_primary_10_1016_j_bulcan_2018_08_002 crossref_primary_10_1182_blood_2013_08_519413 crossref_primary_10_3389_fped_2014_00075 crossref_primary_10_1158_2159_8290_CD_17_0263 crossref_primary_10_1097_PPO_0b013e31824d4465 crossref_primary_10_3389_fimmu_2017_01956 crossref_primary_10_1007_s40472_020_00285_z crossref_primary_10_1016_j_canlet_2011_10_027 crossref_primary_10_1080_02648725_2018_1430465 crossref_primary_10_3390_ijms22073495 crossref_primary_10_1038_gt_2013_25 crossref_primary_10_1080_17474086_2016_1203251 crossref_primary_10_18632_oncotarget_24179 crossref_primary_10_3109_21691401_2015_1052465 crossref_primary_10_1007_s00262_014_1641_9 crossref_primary_10_1186_bcr3674 crossref_primary_10_3389_fimmu_2018_00199 crossref_primary_10_1586_ehm_12_11 crossref_primary_10_3390_cancers15041015 crossref_primary_10_1002_acg2_54 crossref_primary_10_1007_s10238_017_0450_9 crossref_primary_10_1016_j_jaut_2018_02_006 crossref_primary_10_1097_MOH_0000000000000177 crossref_primary_10_1016_j_transci_2023_103828 crossref_primary_10_1002_jgm_2637 crossref_primary_10_1016_j_ymthe_2017_05_024 crossref_primary_10_1080_14712598_2023_2248878 crossref_primary_10_3390_ijms21197424 crossref_primary_10_1016_j_ymthe_2017_09_005 crossref_primary_10_1016_j_ccell_2019_09_006 crossref_primary_10_1371_journal_pone_0057838 crossref_primary_10_1097_MOH_0000000000000190 crossref_primary_10_1158_1078_0432_CCR_18_1811 crossref_primary_10_1111_ajco_13474 crossref_primary_10_1007_s40259_019_00384_z crossref_primary_10_1371_journal_pone_0109427 crossref_primary_10_1371_journal_ppat_1009404 crossref_primary_10_1517_14728222_2015_1068759 crossref_primary_10_1051_e3sconf_201913101001 crossref_primary_10_1038_s43018_021_00241_5 crossref_primary_10_1097_PPO_0000000000000166 crossref_primary_10_1371_journal_pone_0063037 crossref_primary_10_1182_blood_2016_02_629063 crossref_primary_10_1586_17474086_2015_1043884 crossref_primary_10_3109_08830185_2015_1018419 crossref_primary_10_1056_NEJMoa1215134 crossref_primary_10_1586_ehm_12_28 crossref_primary_10_1186_s12943_018_0840_y crossref_primary_10_54097_hset_v36i_5706 crossref_primary_10_1016_j_it_2015_06_004 crossref_primary_10_1007_s12094_023_03122_8 crossref_primary_10_1158_2159_8290_CD_17_1298 crossref_primary_10_3390_cancers14071715 crossref_primary_10_1016_j_jmoldx_2023_06_002 crossref_primary_10_1002_adma_201900192 crossref_primary_10_18632_oncotarget_4071 crossref_primary_10_1155_2017_5210459 crossref_primary_10_1038_s41586_023_05707_3 crossref_primary_10_1016_j_omtm_2022_12_004 crossref_primary_10_3390_cancers13112816 crossref_primary_10_2174_1389450120666191114102830 crossref_primary_10_1631_jzus_B2200256 crossref_primary_10_1016_j_phrs_2021_106036 crossref_primary_10_2147_CMAR_S368588 crossref_primary_10_1182_blood_2012_01_405365 crossref_primary_10_1016_j_addr_2019_01_007 crossref_primary_10_1097_COH_0000000000000284 crossref_primary_10_3892_ijo_2022_5338 crossref_primary_10_1182_blood_2023021243 crossref_primary_10_1002_ijc_28269 crossref_primary_10_1042_BSR20160332 crossref_primary_10_3389_fonc_2024_1394057 crossref_primary_10_1016_j_jconrel_2023_08_033 crossref_primary_10_1016_j_omto_2019_08_008 crossref_primary_10_3389_fimmu_2022_830773 crossref_primary_10_1038_leu_2016_35 crossref_primary_10_1182_blood_2012_12_474056 crossref_primary_10_3389_fimmu_2020_608167 crossref_primary_10_1186_s12896_023_00827_0 crossref_primary_10_1186_s12885_019_5415_9 crossref_primary_10_1016_j_radonc_2022_08_007 crossref_primary_10_1038_nrclinonc_2016_36 crossref_primary_10_1172_jci_insight_92021 crossref_primary_10_3389_fonc_2023_1288383 crossref_primary_10_1016_j_imlet_2019_10_014 crossref_primary_10_1158_1078_0432_CCR_15_1433 crossref_primary_10_1016_j_omton_2024_200814 crossref_primary_10_1007_s11899_017_0398_6 crossref_primary_10_3390_ph7121049 crossref_primary_10_1007_s00262_016_1842_5 crossref_primary_10_1186_s13045_017_0453_8 crossref_primary_10_1208_s12248_025_01017_w crossref_primary_10_1038_leu_2017_39 crossref_primary_10_3390_ijms222111694 crossref_primary_10_1097_MOP_0000000000000866 crossref_primary_10_1007_s40778_017_0077_5 crossref_primary_10_1097_CM9_0000000000000568 crossref_primary_10_1182_asheducation_V2012_1_143_3798224 crossref_primary_10_4049_jimmunol_1801004 crossref_primary_10_1016_j_copbio_2018_01_025 crossref_primary_10_2217_imt_12_1 crossref_primary_10_1111_tan_12090 crossref_primary_10_1038_mt_2011_223 crossref_primary_10_3389_fimmu_2017_00267 crossref_primary_10_1016_j_coi_2015_01_002 crossref_primary_10_1080_2162402X_2022_2083479 crossref_primary_10_2217_imt_15_23 crossref_primary_10_1182_asheducation_2013_1_348 crossref_primary_10_1200_EDBK_200889 crossref_primary_10_1111_ejh_14052 crossref_primary_10_1017_erm_2021_32 crossref_primary_10_3389_fonc_2020_01428 crossref_primary_10_1089_hgtb_2016_153 crossref_primary_10_1172_JCI177160 crossref_primary_10_3389_fonc_2019_00917 crossref_primary_10_1158_1078_0432_CCR_12_2422 crossref_primary_10_1182_bloodadvances_2022007891 crossref_primary_10_1080_14712598_2020_1727436 crossref_primary_10_3389_fimmu_2019_02664 crossref_primary_10_3390_cancers14163972 crossref_primary_10_1016_j_phrs_2017_11_035 crossref_primary_10_1016_j_ymthe_2025_03_005 crossref_primary_10_2217_imt_13_71 crossref_primary_10_1007_s00262_011_1173_5 crossref_primary_10_1038_nrclinonc_2017_128 crossref_primary_10_1016_j_beha_2017_07_009 crossref_primary_10_1182_blood_2018_01_785840 crossref_primary_10_1016_j_heliyon_2024_e27196 crossref_primary_10_2217_imt_15_16 crossref_primary_10_3390_cancers11020191 crossref_primary_10_1182_blood_2011_10_384388 crossref_primary_10_2217_imt_15_15 crossref_primary_10_2217_imt_15_14 crossref_primary_10_2217_imt_14_44 crossref_primary_10_1016_j_molimm_2017_03_017 crossref_primary_10_1016_j_blre_2015_10_003 crossref_primary_10_1016_j_molimm_2014_12_009 crossref_primary_10_1182_asheducation_2016_1_567 crossref_primary_10_1038_cgt_2015_5 crossref_primary_10_4049_jimmunol_1101585 crossref_primary_10_3390_cancers13010038 crossref_primary_10_3390_ijms19010177 crossref_primary_10_1186_s13045_018_0568_6 crossref_primary_10_1371_journal_pone_0082742 crossref_primary_10_1007_s00432_023_05279_9 crossref_primary_10_1182_blood_2020008221 crossref_primary_10_1200_EDBK_200549 crossref_primary_10_1136_bmjopen_2018_026644 crossref_primary_10_4049_jimmunol_1601494 crossref_primary_10_1016_j_pharmthera_2017_03_008 crossref_primary_10_1073_pnas_1817147116 crossref_primary_10_3389_fimmu_2022_886429 crossref_primary_10_1080_21645515_2019_1689744 crossref_primary_10_3389_fbioe_2022_797440 crossref_primary_10_1016_j_ymthe_2018_01_022 crossref_primary_10_1021_mp500392q crossref_primary_10_1182_blood_2011_10_381160 crossref_primary_10_1007_s40259_018_0324_z crossref_primary_10_1111_bjh_12981 crossref_primary_10_1186_s13045_020_00953_8 crossref_primary_10_1146_annurev_med_051914_021702 crossref_primary_10_1038_s41591_018_0036_4 crossref_primary_10_1016_j_tranon_2020_100971 crossref_primary_10_1038_s41551_018_0235_9 crossref_primary_10_1158_1535_7163_MCT_17_1097 crossref_primary_10_1016_j_jaut_2017_08_003 crossref_primary_10_1080_14712598_2022_2026921 crossref_primary_10_1158_2326_6066_CIR_13_0008 crossref_primary_10_1002_mef2_79 crossref_primary_10_1002_advs_201903164 crossref_primary_10_3389_fimmu_2018_02740 crossref_primary_10_3389_fimmu_2018_02861 crossref_primary_10_1111_imr_12139 crossref_primary_10_1007_s12032_018_1149_9 crossref_primary_10_1111_ejh_14103 crossref_primary_10_1111_imr_12136 crossref_primary_10_1111_imr_12130 crossref_primary_10_1111_imr_12131 crossref_primary_10_3389_fbioe_2023_1320807 crossref_primary_10_1007_s11864_020_0706_6 crossref_primary_10_1007_s11899_017_0396_8 crossref_primary_10_3390_cells13090725 crossref_primary_10_3389_fimmu_2023_1253395 crossref_primary_10_1016_j_canlet_2016_12_037 crossref_primary_10_2478_amb_2021_0048 crossref_primary_10_3390_cells11243971 crossref_primary_10_1080_17460441_2024_2319672 crossref_primary_10_2217_imt_2023_0256 crossref_primary_10_1016_j_semcancer_2013_08_011 crossref_primary_10_1016_j_exphem_2019_05_002 crossref_primary_10_1182_asheducation_2013_1_151 crossref_primary_10_3389_fimmu_2018_00239 crossref_primary_10_1016_j_beha_2018_01_002 crossref_primary_10_4254_wjh_v7_i7_980 crossref_primary_10_1053_j_seminhematol_2014_05_006 crossref_primary_10_1182_blood_2011_10_387969 crossref_primary_10_1002_cti2_1421 crossref_primary_10_1111_bjh_17186 crossref_primary_10_1158_2326_6066_CIR_15_0230 crossref_primary_10_3892_mmr_2019_10460 crossref_primary_10_1111_imr_12128 crossref_primary_10_1172_jci_insight_96976 crossref_primary_10_1038_nrclinonc_2016_25 crossref_primary_10_1172_JCI86000 crossref_primary_10_1111_imr_12126 crossref_primary_10_1177_2040620715594736 crossref_primary_10_1007_s40265_019_01071_7 crossref_primary_10_1186_s13045_018_0676_3 crossref_primary_10_1111_imr_12243 crossref_primary_10_1200_JCO_2013_51_5304 crossref_primary_10_7759_cureus_16307 crossref_primary_10_3389_fimmu_2020_01109 crossref_primary_10_1007_s10875_012_9689_9 crossref_primary_10_1016_j_ymthe_2018_09_009 crossref_primary_10_1158_2326_6066_CIR_18_0065 crossref_primary_10_1002_ajh_24238 crossref_primary_10_1016_S0140_6736_14_61729_3 crossref_primary_10_1155_2015_482089 crossref_primary_10_3389_fimmu_2021_681984 crossref_primary_10_1097_CM9_0000000000000638 crossref_primary_10_3389_fcimb_2020_00410 crossref_primary_10_1016_j_ccell_2017_03_002 crossref_primary_10_1111_cas_13239 crossref_primary_10_1371_journal_pone_0130518 crossref_primary_10_1007_s12032_020_01416_3 crossref_primary_10_1371_journal_pone_0093745 crossref_primary_10_1182_blood_2017_02_769208 crossref_primary_10_1146_annurev_cancerbio_061421_012235 crossref_primary_10_3390_biomedicines10081960 crossref_primary_10_1002_med_21818 crossref_primary_10_1126_scitranslmed_abg3072 crossref_primary_10_1007_s12185_012_1037_6 crossref_primary_10_1002_ijc_31147 crossref_primary_10_1007_s00005_023_00683_y crossref_primary_10_1016_j_beha_2016_08_011 crossref_primary_10_1016_j_bbmt_2014_07_018 crossref_primary_10_3389_fimmu_2023_1142597 crossref_primary_10_1016_S0007_4551_19_30046_3 crossref_primary_10_1016_j_coi_2012_08_007 crossref_primary_10_3109_10428194_2012_727417 crossref_primary_10_1038_cgt_2013_35 crossref_primary_10_1016_j_hoc_2017_06_005 crossref_primary_10_3390_medsci2010023 crossref_primary_10_1111_joim_12020 crossref_primary_10_1158_1078_0432_CCR_14_2998 crossref_primary_10_1186_s12943_018_0814_0 crossref_primary_10_1007_s00277_020_04020_7 crossref_primary_10_1126_scisignal_aay9363 crossref_primary_10_2217_imt_12_143 crossref_primary_10_1038_s41587_022_01639_x crossref_primary_10_1038_sigtrans_2016_2 crossref_primary_10_1016_j_ymthe_2017_07_013 crossref_primary_10_1038_mt_2014_58 crossref_primary_10_1007_s00262_016_1895_5 crossref_primary_10_2217_imt_2019_0137 crossref_primary_10_3389_fimmu_2023_1063454 crossref_primary_10_1016_j_isci_2023_106443 crossref_primary_10_1016_j_cellsig_2023_110638 crossref_primary_10_1038_srep28208 crossref_primary_10_1002_wnan_1557 crossref_primary_10_1038_nrclinonc_2013_46 crossref_primary_10_1186_ar3909 crossref_primary_10_1182_blood_2014_11_612721 crossref_primary_10_1089_hum_2016_097 crossref_primary_10_2217_fon_14_288 crossref_primary_10_3389_fimmu_2023_1062365 crossref_primary_10_18632_oncotarget_4362 crossref_primary_10_1038_mt_2013_262 crossref_primary_10_1111_bjh_17153 crossref_primary_10_1002_iub_2180 crossref_primary_10_3389_fimmu_2024_1456443 crossref_primary_10_1038_mt_2014_48 crossref_primary_10_3389_fped_2015_00080 crossref_primary_10_1042_BST20150291 crossref_primary_10_1038_bjc_2013_356 crossref_primary_10_1158_1078_0432_CCR_13_0955 crossref_primary_10_1089_hum_2015_054 crossref_primary_10_1016_j_ijbiomac_2025_141364 crossref_primary_10_1177_20406207221080738 crossref_primary_10_1038_s41434_018_0019_6 crossref_primary_10_1016_j_ccell_2019_12_014 crossref_primary_10_1182_blood_2016_04_703751 crossref_primary_10_1371_journal_pone_0159477 crossref_primary_10_1080_14712598_2018_1384463 crossref_primary_10_3892_ijo_2020_4982 crossref_primary_10_1038_s41467_019_10565_7 crossref_primary_10_18632_oncotarget_5582 crossref_primary_10_1016_S0007_4551_19_30045_1 crossref_primary_10_1007_s12185_013_1479_5 crossref_primary_10_1080_2162402X_2020_1846926 crossref_primary_10_1097_CM9_0000000000002476 crossref_primary_10_1097_HS9_0000000000000988 crossref_primary_10_1016_j_jcyt_2024_05_011 crossref_primary_10_1002_jgm_3484 crossref_primary_10_3389_fimmu_2015_00605 crossref_primary_10_1172_JCI129208 crossref_primary_10_1111_imr_13252 crossref_primary_10_1007_s11899_013_0197_7 crossref_primary_10_1007_s40259_021_00473_y crossref_primary_10_2217_imt_12_33 crossref_primary_10_3390_ijms22042150 crossref_primary_10_1158_2643_3230_BCD_21_0084 crossref_primary_10_1016_j_blre_2019_100645 crossref_primary_10_1186_s13045_019_0758_x crossref_primary_10_1097_PAT_0b013e32834b6b24 crossref_primary_10_1097_PPO_0000000000000514 crossref_primary_10_1111_bjh_15195 crossref_primary_10_1007_s40778_015_0026_0 crossref_primary_10_1016_j_beha_2018_04_001 crossref_primary_10_1039_C9CS00271E crossref_primary_10_3892_etm_2018_7015 crossref_primary_10_1182_blood_2013_06_506741 crossref_primary_10_1186_s12929_023_00982_8 crossref_primary_10_1517_14712598_2015_1014792 crossref_primary_10_1016_j_clim_2014_10_002 crossref_primary_10_1056_NEJMc1111004 crossref_primary_10_1038_nrclinonc_2014_177 crossref_primary_10_1080_21645515_2016_1268745 crossref_primary_10_1016_j_hoc_2012_12_004 crossref_primary_10_1038_nm_3833 crossref_primary_10_1016_j_hoc_2023_12_004 crossref_primary_10_1038_nm_3838 crossref_primary_10_1007_s11899_017_0394_x crossref_primary_10_1158_1078_0432_CCR_18_1211 crossref_primary_10_1007_s11899_016_0336_z crossref_primary_10_1080_2162402X_2016_1251539 crossref_primary_10_18632_oncotarget_19361 crossref_primary_10_1016_j_heliyon_2023_e21329 crossref_primary_10_1517_14712598_2014_860442 crossref_primary_10_2174_1566523218666181116093857 crossref_primary_10_1186_s13045_019_0704_y crossref_primary_10_3109_10428194_2012_715350 crossref_primary_10_1002_cti2_1049 crossref_primary_10_1016_j_coche_2012_05_002 crossref_primary_10_1038_leu_2017_57 crossref_primary_10_1158_1078_0432_CCR_14_2675 crossref_primary_10_1007_s41745_018_0062_8 crossref_primary_10_1016_j_clim_2020_108382 crossref_primary_10_1016_j_imlet_2017_08_018 crossref_primary_10_1186_s12985_021_01501_7 crossref_primary_10_1016_j_phrs_2025_107608 crossref_primary_10_1182_blood_2011_12_400044 crossref_primary_10_2217_imt_12_12 crossref_primary_10_1038_gt_2017_81 crossref_primary_10_1182_blood_2015_12_629089 crossref_primary_10_1002_mco2_146 crossref_primary_10_1038_bmt_2015_184 crossref_primary_10_1007_s00432_022_04547_4 crossref_primary_10_1016_j_tranon_2021_101085 crossref_primary_10_1097_CJI_0000000000000199 crossref_primary_10_1016_j_adcanc_2023_100090 crossref_primary_10_3390_cells9030601 crossref_primary_10_1016_j_pan_2020_02_006 crossref_primary_10_1016_j_exphem_2016_07_011 crossref_primary_10_4103_1319_2442_390259 crossref_primary_10_1038_mt_2014_148 crossref_primary_10_1038_mto_2016_14 crossref_primary_10_1182_blood_2015_01_621474 crossref_primary_10_60043_2949_5938_2024_2_10_23 crossref_primary_10_1016_j_molmed_2017_03_002 crossref_primary_10_1177_2399369319863433 crossref_primary_10_1016_j_ymthe_2017_01_011 crossref_primary_10_1007_s12254_021_00703_7 crossref_primary_10_1182_blood_2011_12_398719 crossref_primary_10_1097_HC9_0000000000000022 crossref_primary_10_1038_mt_2013_110 crossref_primary_10_1080_1744666X_2017_1366315 crossref_primary_10_1007_s00005_020_00599_x crossref_primary_10_1111_bjh_14078 crossref_primary_10_1136_jitc_2022_005519 crossref_primary_10_1134_S1068162017020091 crossref_primary_10_1042_BST20150266 crossref_primary_10_1186_1824_7288_37_46 crossref_primary_10_1016_j_ebiom_2020_102931 crossref_primary_10_1038_mtna_2013_32 crossref_primary_10_1182_blood_2022015728 crossref_primary_10_1186_s40164_020_00190_2 crossref_primary_10_1126_scitranslmed_abb5191 crossref_primary_10_1182_blood_2015_06_650812 crossref_primary_10_1080_08830185_2021_1984449 crossref_primary_10_14338_IJPT_20_00004_1 crossref_primary_10_3389_fimmu_2023_1179827 crossref_primary_10_1586_17474086_2016_1122513 crossref_primary_10_3390_cancers13174279 crossref_primary_10_1016_j_bcmd_2016_11_001 crossref_primary_10_1002_jcb_28250 crossref_primary_10_1007_s12672_024_01638_1 crossref_primary_10_3389_fimmu_2018_00507 crossref_primary_10_3389_fimmu_2018_01717 crossref_primary_10_1097_MOH_0000000000000614 crossref_primary_10_1002_jcp_25419 crossref_primary_10_1371_journal_pone_0199414 crossref_primary_10_1146_annurev_med_060512_150254 crossref_primary_10_1186_s40425_018_0343_9 crossref_primary_10_1007_s00018_022_04421_z crossref_primary_10_1016_j_currproblcancer_2021_100826 crossref_primary_10_1158_2326_6066_CIR_17_0126 crossref_primary_10_3390_cells9091971 crossref_primary_10_1038_s41587_022_01245_x crossref_primary_10_1186_1476_4598_13_219 crossref_primary_10_1016_j_ymthe_2020_05_012 crossref_primary_10_1007_s40259_015_0122_9 crossref_primary_10_1016_j_exphem_2016_10_009 crossref_primary_10_1021_acs_jmedchem_0c02054 crossref_primary_10_3389_fimmu_2017_01939 crossref_primary_10_1007_s13402_021_00593_1 crossref_primary_10_1007_s12185_013_1490_x crossref_primary_10_18632_oncotarget_24637 crossref_primary_10_1038_nrc3565 crossref_primary_10_1038_leu_2016_373 crossref_primary_10_1016_j_canlet_2013_10_004 crossref_primary_10_1016_j_coi_2016_06_004 crossref_primary_10_1016_j_imlet_2013_09_014 crossref_primary_10_1016_j_jcyt_2019_04_060 crossref_primary_10_1042_BST20170178 crossref_primary_10_1182_blood_2017_06_793869 crossref_primary_10_1634_theoncologist_2015_0421 crossref_primary_10_3390_cancers8070064 crossref_primary_10_3389_fmicb_2018_03158 crossref_primary_10_1038_cgt_2014_81 crossref_primary_10_1159_000357163 crossref_primary_10_1016_j_blre_2018_11_002 crossref_primary_10_1177_1758835920962963 crossref_primary_10_3389_fmed_2023_1135468 crossref_primary_10_1016_j_jgg_2017_09_002 crossref_primary_10_1111_sji_13268 crossref_primary_10_3389_fimmu_2016_00500 crossref_primary_10_1038_nrclinonc_2015_187 crossref_primary_10_1016_j_biopha_2019_109685 crossref_primary_10_1002_ajh_27283 crossref_primary_10_1016_j_omto_2022_12_003 crossref_primary_10_1111_trf_14003 crossref_primary_10_1155_2016_5474602 crossref_primary_10_1002_ctm2_70140 crossref_primary_10_3389_fmed_2024_1447147 crossref_primary_10_1002_cnr2_1222 crossref_primary_10_15302_J_QB_021_0253 crossref_primary_10_3109_08880018_2013_802106 crossref_primary_10_1038_nrd4597 crossref_primary_10_1016_j_autrev_2019_02_005 crossref_primary_10_1016_j_imlet_2016_03_007 crossref_primary_10_1038_s41409_019_0604_3 crossref_primary_10_1002_cncr_32764 crossref_primary_10_1134_S0026893317020145 crossref_primary_10_1089_hum_2021_165 crossref_primary_10_3390_vaccines10030457 crossref_primary_10_1016_j_bbmt_2012_10_021 crossref_primary_10_1016_j_intimp_2020_106351 crossref_primary_10_1038_s41375_017_0008_6 crossref_primary_10_1007_s00277_018_3368_8 crossref_primary_10_1158_2326_6066_CIR_14_0186 crossref_primary_10_3389_fimmu_2022_822004 crossref_primary_10_1007_s12185_022_03398_6 crossref_primary_10_1089_hum_2012_202 crossref_primary_10_3390_cancers13164040 crossref_primary_10_3390_v15030789 crossref_primary_10_1186_s13045_017_0437_8 crossref_primary_10_3390_cells8050472 crossref_primary_10_1186_s13643_021_01588_7 crossref_primary_10_3390_ijms22052476 crossref_primary_10_1007_s12185_021_03191_x crossref_primary_10_3389_fphar_2022_950923 crossref_primary_10_1016_j_leukres_2017_06_011 crossref_primary_10_1016_j_trsl_2017_07_002 crossref_primary_10_1016_j_clml_2022_12_015 crossref_primary_10_1089_hum_2016_025 crossref_primary_10_1158_2159_8290_CD_12_0548 crossref_primary_10_1038_mto_2016_24 crossref_primary_10_1080_14737140_2018_1451749 crossref_primary_10_1016_j_omto_2021_06_006 crossref_primary_10_1038_s41375_020_0930_x crossref_primary_10_3389_fimmu_2023_1188049 crossref_primary_10_1038_bcj_2016_61 crossref_primary_10_1053_j_seminoncol_2014_08_005 crossref_primary_10_2217_fon_2020_0291 crossref_primary_10_1016_S2152_2650_20_30475_4 crossref_primary_10_1038_s41571_022_00704_3 crossref_primary_10_1111_imm_12784 crossref_primary_10_4049_jimmunol_1302148 crossref_primary_10_1158_1078_0432_CCR_13_0330 crossref_primary_10_2217_imt_2016_0112 crossref_primary_10_7759_cureus_59951 crossref_primary_10_1016_j_phrs_2016_07_019 crossref_primary_10_1042_BST20160037 crossref_primary_10_5402_2012_278093 crossref_primary_10_3109_08830185_2011_595855 crossref_primary_10_1159_000442170 crossref_primary_10_1016_j_mtbio_2023_100615 crossref_primary_10_1371_journal_pone_0061338 crossref_primary_10_3892_ol_2018_8617 crossref_primary_10_1158_2326_6066_CIR_21_0307 crossref_primary_10_1089_hum_2014_045 crossref_primary_10_1016_j_jcyt_2016_05_001 crossref_primary_10_1016_j_smim_2015_12_001 crossref_primary_10_1002_jcp_27599 crossref_primary_10_1016_j_transci_2018_04_019 crossref_primary_10_1186_s40164_024_00553_z crossref_primary_10_1111_ajt_14185 crossref_primary_10_1182_blood_2013_11_541235 crossref_primary_10_1016_j_beha_2018_05_001 crossref_primary_10_1016_j_intimp_2024_111631 crossref_primary_10_1016_j_bcp_2019_06_002 crossref_primary_10_1016_j_jcyt_2014_02_001 crossref_primary_10_1200_EDBK_180328 crossref_primary_10_1186_s40364_022_00417_w crossref_primary_10_1007_s00262_015_1757_6 crossref_primary_10_1016_j_jcyt_2013_02_007 crossref_primary_10_3390_ijms21010204 crossref_primary_10_4161_onci_28344 crossref_primary_10_1056_NEJMoa1407222 crossref_primary_10_1182_bloodadvances_2021004535 crossref_primary_10_1038_s41392_019_0070_9 crossref_primary_10_3390_cells9061485 crossref_primary_10_1038_cti_2014_7 crossref_primary_10_1126_scitranslmed_aaa4963 crossref_primary_10_1007_s40265_017_0690_8 crossref_primary_10_1007_s40778_017_0101_9 crossref_primary_10_1016_j_annonc_2021_07_018 crossref_primary_10_1016_j_jcyt_2019_02_013 crossref_primary_10_1038_s41568_022_00491_0 crossref_primary_10_1038_s41598_021_85747_9 crossref_primary_10_1080_14728222_2019_1602608 crossref_primary_10_1186_s12885_018_4817_4 crossref_primary_10_4161_21505594_2014_988098 crossref_primary_10_1126_scitranslmed_aaf8621 crossref_primary_10_4161_hv_27637 crossref_primary_10_1007_s11684_021_0843_8 crossref_primary_10_1186_1756_8722_6_47 crossref_primary_10_1016_j_genrep_2024_101979 crossref_primary_10_1172_JCI186113 crossref_primary_10_2217_imt_2017_0062 crossref_primary_10_1186_s13045_018_0572_x crossref_primary_10_1016_j_critrevonc_2019_01_015 crossref_primary_10_3390_cancers14051241 crossref_primary_10_3390_cancers15133476 crossref_primary_10_1111_ejh_12602 crossref_primary_10_1155_2014_525913 crossref_primary_10_1017_erm_2015_14 crossref_primary_10_1038_s41467_023_40852_3 crossref_primary_10_1200_JCO_2014_58_0225 crossref_primary_10_1182_blood_2012_02_410373 crossref_primary_10_1111_imr_12812 crossref_primary_10_1038_mt_2014_8 crossref_primary_10_1007_s12094_020_02490_9 crossref_primary_10_1080_14656566_2017_1340938 crossref_primary_10_2217_fon_2021_1090 crossref_primary_10_1038_s41591_019_0737_3 crossref_primary_10_1186_s13045_023_01455_z crossref_primary_10_1172_JCI94306 crossref_primary_10_1016_j_tracli_2015_05_002 crossref_primary_10_3389_fimmu_2021_670286 crossref_primary_10_2217_imt_2017_0072 crossref_primary_10_22159_ajpcr_2024v17i7_50815 crossref_primary_10_1007_s12094_024_03774_0 crossref_primary_10_1111_bjh_14475 crossref_primary_10_1186_1756_8722_6_33 crossref_primary_10_1016_j_medcli_2020_05_007 crossref_primary_10_1038_s41419_024_06734_2 crossref_primary_10_1111_j_1399_0039_2011_01799_x crossref_primary_10_3389_fmolb_2021_756599 crossref_primary_10_1016_j_trsl_2017_06_003 crossref_primary_10_1517_14712598_2014_920813 crossref_primary_10_1186_s40425_017_0223_8 crossref_primary_10_2174_0109298673268932230920063933 crossref_primary_10_1111_bjh_14470 crossref_primary_10_1016_j_nec_2020_06_014 crossref_primary_10_1158_0008_5472_CAN_14_1530 crossref_primary_10_1586_1744666X_2014_865519 crossref_primary_10_1080_14712598_2024_2404100 crossref_primary_10_1177_2040620719841581 crossref_primary_10_2217_imt_12_162 crossref_primary_10_1016_j_cdtm_2018_08_002 crossref_primary_10_1016_S2352_3026_19_30115_2 crossref_primary_10_3389_fimmu_2018_03180 crossref_primary_10_1126_scitranslmed_3002842 crossref_primary_10_1016_j_trsl_2017_06_011 crossref_primary_10_1080_14712598_2018_1384810 crossref_primary_10_1172_JCI80010 crossref_primary_10_1200_JCO_2014_57_5472 crossref_primary_10_1016_j_cpt_2022_12_002 crossref_primary_10_1097_MS9_0000000000001375 crossref_primary_10_1038_mt_2014_208 crossref_primary_10_2217_imt_11_135 crossref_primary_10_1038_bmt_2011_155 crossref_primary_10_1002_cpt_392 crossref_primary_10_1080_13543784_2022_2032642 crossref_primary_10_1158_0008_5472_CAN_14_0697 crossref_primary_10_3389_fimmu_2023_1260470 crossref_primary_10_1038_cgt_2012_74 crossref_primary_10_1186_s40425_018_0347_5 crossref_primary_10_1038_mt_2015_119 crossref_primary_10_1038_nature22395 crossref_primary_10_1158_2326_6066_CIR_14_0127 crossref_primary_10_1007_s00262_021_03009_z |
Cites_doi | 10.1200/JCO.2006.09.2403 10.1073/pnas.0813101106 10.1182/blood-2010-04-281931 10.1182/blood-2007-05-091280 10.1158/1078-0432.CCR-06-1183 10.1038/nrc1586 10.1038/nri2635 10.1016/j.bbmt.2010.03.014 10.1038/sj.leu.2403302 10.1200/JCO.2005.00.240 10.1016/j.ymthe.2005.04.016 10.1126/science.1129003 10.1038/nrc2355 10.1038/nri727 10.1073/pnas.90.2.720 10.1038/ni0302-221 10.1016/S0161-5890(97)00144-2 10.1038/nm.1882 10.1038/nm827 10.1182/blood-2007-12-128843 10.1182/blood-2010-01-043737 10.1016/j.coi.2009.02.009 10.1038/nbt0102-70 10.1182/blood-2002-07-1989 10.1182/blood-2006-04-017061 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2011 American Society for Clinical Investigation Copyright American Society for Clinical Investigation May 2011 Copyright © 2011, American Society for Clinical Investigation |
Copyright_xml | – notice: COPYRIGHT 2011 American Society for Clinical Investigation – notice: Copyright American Society for Clinical Investigation May 2011 – notice: Copyright © 2011, American Society for Clinical Investigation |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7RV 7X7 7XB 88A 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS S0X 7X8 5PM |
DOI | 10.1172/JCI46110 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Nursing & Allied Health Database (Proquest) Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection eLibrary Curriculum ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Health & Medical Collection Proquest Medical Database Biological Science Database (Proquest) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China SIRS Editorial MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials SIRS Editorial elibrary ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1558-8238 |
EndPage | 1826 |
ExternalDocumentID | PMC3083795 2346315351 A256205801 21540550 10_1172_JCI46110 |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: 3P50CA126752 – fundername: NCI NIH HHS grantid: P30 CA125123 – fundername: NCI NIH HHS grantid: P50 CA126752 – fundername: NCI NIH HHS grantid: P01 CA094237 |
GroupedDBID | --- -~X .55 .XZ 08G 08P 29K 354 36B 5GY 5RE 5RS 7RV 7X7 88E 8AO 8F7 8FE 8FH 8FI 8FJ 8R4 8R5 AAWTL AAYOK AAYXX ABOCM ABPMR ABUWG ACGFO ACIHN ACNCT ACPRK ADBBV AEAQA AENEX AFCHL AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS ASPBG AVWKF AZFZN BAWUL BBNVY BCR BCU BEC BENPR BHPHI BKEYQ BLC BPHCQ BVXVI CCPQU CITATION CS3 D-I DIK DU5 E3Z EBD EBS EJD EMB EMOBN EX3 F5P FRP FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IEA IHR IHW INH IOF IOV IPO ISR ITC KQ8 L7B LK8 M1P M5~ M7P NAPCQ OBH OCB ODZKP OFXIZ OGEVE OHH OK1 OVD OVIDX OVT P2P P6G PHGZM PHGZT PQQKQ PROAC PSQYO Q2X RPM S0X SJFOW SV3 TEORI TR2 TVE UKHRP VVN W2D WH7 WOQ WOW X7M XSB YFH YHG YKV YOC ZY1 ~H1 .GJ 2WC 3O- 53G AAKAS ADZCM AFFNX AI. CGR CUY CVF ECM EIF FEDTE HVGLF H~9 J5H MVM N4W NPM OHT PJZUB PPXIY PQGLB UHU VH1 ZGI ZXP PMFND 3V. 7XB 88A 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c602t-a52399a9aa6c4ac5baf14f4f52fc898a21ff4264bb0830ba7a0600d6986e4fe13 |
IEDL.DBID | 7X7 |
ISSN | 0021-9738 1558-8238 |
IngestDate | Thu Aug 21 18:28:40 EDT 2025 Fri Jul 11 05:37:08 EDT 2025 Fri Jul 25 19:18:04 EDT 2025 Tue Jun 17 21:34:57 EDT 2025 Thu Jun 12 23:26:39 EDT 2025 Tue Jun 10 20:25:43 EDT 2025 Fri Jun 27 04:37:55 EDT 2025 Fri Jun 27 03:43:09 EDT 2025 Thu May 22 21:08:57 EDT 2025 Mon Jul 21 06:06:39 EDT 2025 Tue Jul 01 00:54:19 EDT 2025 Thu Apr 24 22:57:20 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c602t-a52399a9aa6c4ac5baf14f4f52fc898a21ff4264bb0830ba7a0600d6986e4fe13 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-General Information-1 content type line 14 ObjectType-Feature-3 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://www.jci.org/articles/view/46110/files/pdf |
PMID | 21540550 |
PQID | 866366814 |
PQPubID | 42166 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3083795 proquest_miscellaneous_865187693 proquest_journals_866366814 gale_infotracmisc_A256205801 gale_infotracgeneralonefile_A256205801 gale_infotracacademiconefile_A256205801 gale_incontextgauss_ISR_A256205801 gale_incontextgauss_IOV_A256205801 gale_healthsolutions_A256205801 pubmed_primary_21540550 crossref_primary_10_1172_JCI46110 crossref_citationtrail_10_1172_JCI46110 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-05-01 |
PublicationDateYYYYMMDD | 2011-05-01 |
PublicationDate_xml | – month: 05 year: 2011 text: 2011-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Ann Arbor |
PublicationTitle | The Journal of clinical investigation |
PublicationTitleAlternate | J Clin Invest |
PublicationYear | 2011 |
Publisher | American Society for Clinical Investigation |
Publisher_xml | – name: American Society for Clinical Investigation |
References | B20 B21 B22 B23 B24 B25 Brentjens (B18) 2003; 9 B10 B11 B12 B13 B14 B15 B16 B17 B19 B1 B2 B3 B4 B5 B6 B7 B8 B9 22091680 - Immunotherapy. 2011 Dec;3(12):1441-3. doi: 10.2217/imt.11.135. |
References_xml | – ident: B24 doi: 10.1200/JCO.2006.09.2403 – ident: B14 doi: 10.1073/pnas.0813101106 – ident: B8 doi: 10.1182/blood-2010-04-281931 – ident: B2 doi: 10.1182/blood-2007-05-091280 – ident: B10 doi: 10.1158/1078-0432.CCR-06-1183 – ident: B11 doi: 10.1038/nrc1586 – ident: B6 doi: 10.1038/nri2635 – ident: B19 doi: 10.1016/j.bbmt.2010.03.014 – ident: B13 doi: 10.1038/sj.leu.2403302 – ident: B20 doi: 10.1200/JCO.2005.00.240 – ident: B15 doi: 10.1016/j.ymthe.2005.04.016 – ident: B21 doi: 10.1126/science.1129003 – ident: B1 doi: 10.1038/nrc2355 – ident: B22 doi: 10.1038/nri727 – ident: B4 doi: 10.1073/pnas.90.2.720 – ident: B23 doi: 10.1038/ni0302-221 – ident: B16 doi: 10.1016/S0161-5890(97)00144-2 – ident: B3 doi: 10.1038/nm.1882 – volume: 9 start-page: 279 year: 2003 ident: B18 publication-title: Nat Med. doi: 10.1038/nm827 – ident: B9 doi: 10.1182/blood-2007-12-128843 – ident: B7 doi: 10.1182/blood-2010-01-043737 – ident: B5 doi: 10.1016/j.coi.2009.02.009 – ident: B12 doi: 10.1038/nbt0102-70 – ident: B17 doi: 10.1182/blood-2002-07-1989 – ident: B25 doi: 10.1182/blood-2006-04-017061 – reference: 22091680 - Immunotherapy. 2011 Dec;3(12):1441-3. doi: 10.2217/imt.11.135. |
SSID | ssj0014454 |
Score | 2.5756667 |
Snippet | Targeted T cell immunotherapies using engineered T lymphocytes expressing tumor-directed chimeric antigen receptors (CARs) are designed to benefit patients... |
SourceID | pubmedcentral proquest gale pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1822 |
SubjectTerms | Antigens Antigens, CD19 - metabolism Biomedical research Brief Report Care and treatment CD28 Antigens - metabolism Cell receptors Development and progression Female Human subjects Humans Immunophenotyping Immunotherapy Immunotherapy - methods Lymphocyte Activation Lymphocytes Lymphoma Lymphoma - metabolism Lymphoma, B-Cell - metabolism Lymphoma, Non-Hodgkin - metabolism Lymphomas Male Middle Aged Patients Physiological aspects Positron-Emission Tomography - methods Protein Structure, Tertiary Retroviridae - genetics T cells T-Lymphocytes - metabolism Tomography, X-Ray Computed - methods |
Title | CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/21540550 https://www.proquest.com/docview/866366814 https://www.proquest.com/docview/865187693 https://pubmed.ncbi.nlm.nih.gov/PMC3083795 |
Volume | 121 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1NT9wwELUoSFUvVaFfKZS6VVVOEets_JFTBQuIpYJWFKq9RY5jQyQ22Ta7Ev33nUm80aZCVY-RX6TEHnuex-M3hHzMwGtrHYkwZzYL40jiZeVchhq4LDfcSOswDnl-IU6v47MJn_jcnNqnVS7XxGahziuDMfJ9Ba5RCMXiz7OfIRaNwsNVX0HjEdlA5TLM6JKTbr8FWwXuRZhZmMih8tqz4LL3z0bjWDC8Nrvijf5ek1ecUj9hcsUDnTwjTz11pAftWG-SNVtukcfn_nD8ObkfHUWKmgom7dQX5aJFEzOwNbX3MO0xMkZ1mdMZRsnqhi7TylFzWzQHN9A2R3VOCsugncFuPJxWeeGApdIriiH-mhYlvfsNFlBNNfWarPULcn1yfDU6DX1hhdCIQTQPNccbrTrRWphYG55px2IXOx45oxKlI-YcMqUsA4I2yLTUA-BFuUiUsLGzbPiSrJdVaV8TyhzTXJo80Vi7mgHBiLJEKwO7FCesSgKyt-zg1HjVcSx-cZc2uw8ZpcuhCMj7DjlrlTYewLzDMUrbO6Ld5EwPgLhFAw7eNiAfGgRKW5SYO3OjF3Wdjr_--A_Q98seaM-DXAVfbLS_rwD_jZJZPeSnHvKmFQx_CLjTA8JMNr3m7aXppX4lqdPO7gNCu1Z8EZPjSlstEMKZwpqWAXnV2mnXgUDogJFz6DjZs-AOgOri_ZayuG1Uxocw9jLhb_75UdvkSRtkxwzQHbI-_7Wwb4GlzbPdZi7uko3D44tvl_B0NP7yBwKqPvg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwEvE990G8wgYE_RajfOxwNCo9vUbmtBo5v2FhzH3iqtSSGt2P4o_kfuEidq0IR42bN_jVL7cve7830Q8i4Gqy0l95yE6dhxuY_FyonvSOCyQgnla4NxyOHI65-6h-fifIX8rmphMK2y0omFok4yhTHynQBMo-cFzP00--Hg0Ci8XK0maJRScaRvfoHHln8c7MHxvuf8YH_c6zt2qICjvA6fO1JgNacMpfSUK5WIpWGucY3gRgVhIDkzBllCHAM56cTSlx3gBIkXBp52jWZdeO49sup2wZNpkdXP-6OvJ_W1hesK2_aZOaHfDWy3WyAJO4e9gesxLNRdsn9_W4ElM9hM0VyyeQePyJolq3S3lK7HZEWnT8j9ob2Of0que3s8oCoDNTG1Y8DopIhS6Jzqa1A0GIujMk3oDONyeUHQaWaoupwUV0WwNsd-oBQUr56B_-9Ms2RigBfTMcVLhZxOUnp1AzKXTSW1XWDzZ-T0Tnb9OWmlWapfEsoMk8JXSShxWjYDSsPjUAYK_CLj6SBsk-1qgyNl-5zjuI2rqPB3fB5VR9Emb2rkrOztcQtmC88oKqtSa3UQ7QJV5B0B9r1N3hYIbKaRYrbOhVzkeTT4cvYfoG8nDdC2BZkM3lhJWyEB_xubdDWQHxrIi7JF-W3AzQYQdIdqLG9UohdZ3ZVH9ZfWJrRexR9iOl6qswVCBAtwimabvCjltN5AoJDgAwjYOL8hwTUA-5k3V9LJZdHXvAtn74di_Z8vtUUe9MfD4-h4MDraIA_LED_mn26S1vznQr8CjjiPX9svk5Lvd60M_gBnWXsQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwELbGkCZeEL8pG8wgYE9RazeOkweEppZq3dhAsKG-ZY5jb5XWpCyt2P40_jvuEidq0IR42bO_RIl9vvvu7Lsj5G0CVlspHngpM4nnc4nJyqn0FHBZoYWWxmIc8vAo2Dvx9ydiskZ-17kweK2y1omlok5zjTHybgimMQhC5netuxXxdTj6OP_pYQMpPGitu2lUEnJgrn-B91Z8GA9hqd9xPvp0PNjzXIMBTwc9vvCUwMxOFSkVaF9pkSjLfOtbwa0Oo1BxZi0yhiQBotJLlFQ94AdpEIWB8a1hfXjvHXJX9gXDLSYnja8HbopwBaCZF8l-6OreAl3o7g_GfsAwZXfFEv5tD1YMYvuy5or1Gz0g9x1tpbuVnD0kayZ7RDYO3cH8Y3I1GPKQ6hwUxsw1BKPTMl5hCmquQOVgVI6qLKVzjNAVJVWnuaX6fFoeGsHYAiuDUlDBZr7IL71Znk4tMGR6TPF4oaDTjF5cg_TlM0VdPdjiCTm5lTl_StazPDPPCWWWKSF1Ginsm82A3PAkUqEGD8kGJow6ZKee4Fi7iufYeOMiLj0fyeN6KTrkdYOcV1U-bsBs4xrFVX5qoxjiXSCNvCfA0nfImxKBZTUylNAztSyKePzlx3-Avn9rgXYcyObwxVq5XAn4byzX1UK-byHPqmLlNwG3WkDQIro1vFmLXuy0WBE3e65DaDOKD-LFvMzkS4QIFmI_zQ55VslpM4FAJsEbEDBxsiXBDQArm7dHsul5WeG8D2svI_Hinx-1TTZABcSfx0cHm-ReFevHi6hbZH1xuTQvgSwuklfltqTk9Lb1wB-xvn3g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CD28+costimulation+improves+expansion+and+persistence+of+chimeric+antigen+receptor-modified+T+cells+in+lymphoma+patients&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Savoldo%2C+Barbara&rft.au=Ramos%2C+Carlos+Almeida&rft.au=Liu%2C+Enli&rft.au=Mims%2C+Martha+P&rft.date=2011-05-01&rft.pub=American+Society+for+Clinical+Investigation&rft.issn=0021-9738&rft.volume=121&rft.issue=5&rft.spage=1822&rft_id=info:doi/10.1172%2FJCI46110&rft.externalDBID=ISR&rft.externalDocID=A256205801 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9738&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9738&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9738&client=summon |